NAD+ × glowaminos peptides — lab test, February 2026
Ethos Analytics publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
This certificate carries no lookup code.
Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 1500 mg · Lab measured 1589.57 mg
106% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 397.4 mg using the measured mass, against 375 mg on the label — 6% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
Independent HPLC purity analysis of NAD+ from glowaminos peptides, performed by Ethos Analytics on February 22, 2026. Reported purity: 98%. Net content: 1589.57 mg against 1500 mg labeled (106% of label). Endotoxins: <1.25 EU/ml. Batch GL-010017. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of NAD+ from glowaminos peptides
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| GL-010134 | 3 Jun 2026 | ILS Laboratories | 99.75% | 103% | ✓ Lab-verified |
| GL-010112 | 14 May 2026 | ILS Laboratories | 99.37% | 105% | ✓ Lab-verified |
| GL-010158 | 6 Apr 2026 | ILS Laboratories | 99.04% | 102% | ✓ Lab-verified |
| GL-010040 | 26 Feb 2026 | freedomdiagnosticstesting.com | 99.834% | 98% | ✓ Lab-verified |
| GL-010036 | 22 Feb 2026 | freedomdiagnosticstesting.com | 99.849% | 120% | ✓ Lab-verified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion